Who invested in Alexza Pharmaceuticals?
Alexza Pharmaceuticals's investors include New Enterprise Associates, Versant Ventures, Alloy Ventures, CMEA Ventures and Frazier Healthcare Partners, and 2 more on record.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$114Mraised across 5 rounds since 2002, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $3K sold, first sale Mar 2014
No investor was named in the report.
Reported by sec.govSEC filing: $3.0M sold, first sale Mar 2012
No investor was named in the report.
Reported by deals.venturebeat.comSEC filing: $1.0M sold, first sale May 2010
No investor was named in the report.
From a historical funding recordSEC filing: $20M sold, first sale Oct 2009
From a historical funding record
From the SEC filings it signed: 2 on the team.
On the board, as filediDeepika R PakianathanGordon Leighton RingoldIsaac Leighton SteinJ Kevin BuchiJ Leighton ReadJoseph L Turner
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Alexza Pharmaceuticals's investors include New Enterprise Associates, Versant Ventures, Alloy Ventures, CMEA Ventures and Frazier Healthcare Partners, and 2 more on record.
Alexza Pharmaceuticals has raised $114M across 5 rounds since 2002.
Alexza Pharmaceuticals's most recent round was an Undisclosed round of $45M in Mar 2014.
Its most recent round, $45M in Mar 2014, is also its largest on record.
Alexza Pharmaceuticals's first round on record, in Sept 2002, was backed by New Enterprise Associates, Versant Ventures and Alloy Ventures and 4 others.
Alexza Pharmaceuticals's latest named round is an Undisclosed round, in Mar 2014.
Alexza Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.